Literature DB >> 11102442

Calpain mutants with increased Ca2+ sensitivity and implications for the role of the C(2)-like domain.

C M Hosfield1, T Moldoveanu, P L Davies, J S Elce, Z Jia.   

Abstract

The ubiquitous calpain isoforms (mu- and m-calpain) are Ca(2+)-dependent cysteine proteases that require surprisingly high Ca(2+) concentrations for activation in vitro ( approximately 50 and approximately 300 microm, respectively). The molecular basis of such a high requirement for Ca(2+) in vitro is not known. In this study, we substantially reduced the concentration of Ca(2+) required for the activation of m-calpain in vitro through the specific disruption of interdomain interactions by structure-guided site-directed mutagenesis. Several interdomain electrostatic interactions involving lysine residues in domain II and acidic residues in the C(2)-like domain III were disrupted, and the effects of these mutations on activity and Ca(2+) sensitivity were analyzed. The mutation to serine of Glu-504, a residue that is conserved in both mu- and m-calpain and interacts most notably with Lys-234, reduced the in vitro Ca(2+) requirement for activity by almost 50%. The mutation of Lys-234 to serine or glutamic acid resulted in a similar reduction. These are the first reported cases in which point mutations have been able to reduce the Ca(2+) requirement of calpain. The structures of the mutants in the absence of Ca(2+) were shown by x-ray crystallography to be unchanged from the wild type, demonstrating that the increase in Ca(2+) sensitivity was not attributable to conformational change prior to activation. The conservation of sequence between mu-calpain, m-calpain, and calpain 3 in this region suggests that the results can be extended to all of these isoforms. Whereas the primary Ca(2+) binding is assumed to occur at EF-hands in domains IV and VI, these results show that domain II-domain III salt bridges are important in the process of the Ca(2+)-induced activation of calpain and that they influence the overall Ca(2+) requirement of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11102442     DOI: 10.1074/jbc.M007352200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Multiple interactions of the 'transducer' govern its function in calpain activation by Ca2+.

Authors:  Zoltán Bozóky; Anita Alexa; Peter Tompa; Peter Friedrich
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

2.  Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain.

Authors:  Hidenori Shiraha; Angela Glading; Jeffrey Chou; Zongchao Jia; Alan Wells
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

3.  Calpain 6 is involved in microtubule stabilization and cytoskeletal organization.

Authors:  Kazuo Tonami; Yukiko Kurihara; Hiroyuki Aburatani; Yasunobu Uchijima; Tomoichiro Asano; Hiroki Kurihara
Journal:  Mol Cell Biol       Date:  2007-01-08       Impact factor: 4.272

4.  Cysteine proteases and cell differentiation: excystment of the ciliated protist Sterkiella histriomuscorum.

Authors:  Eduardo Villalobo; Clara Moch; Ghislaine Fryd-Versavel; Anne Fleury-Aubusson; Loïc Morin
Journal:  Eukaryot Cell       Date:  2003-12

5.  Electrostatic interactions of domain III stabilize the inactive conformation of mu-calpain.

Authors:  Amaury Fernández-Montalván; Irmgard Assfalg-Machleidt; Dietmar Pfeiler; Hans Fritz; Marianne Jochum; Werner Machleidt
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

6.  Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression.

Authors:  Marina Fanin; Anna Chiara Nascimbeni; Luigi Fulizio; Carlo Pietro Trevisan; Marija Meznaric-Petrusa; Corrado Angelini
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

7.  Homology modeling study of bovine μ-calpain inhibitor-binding domains.

Authors:  Han-Ha Chai; Dajeong Lim; Seung-Hwan Lee; Hee-Yeoul Chai; Eunkyoung Jung
Journal:  Int J Mol Sci       Date:  2014-05-06       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.